Is BioLife Solutions, Inc. (BLFS) a Buy, Sell, or Hold?
NASDAQ : BLFS
BioLife Solutions, Inc.
$31.15 USD
$1.96 (6.71%)
- Volume
- 9.73M
- Average Volume
- 775.48K
- Market Capitalization
- $1.52B
- P/E Ratio
- -144.21
- Dividend Yield
- 0.00%
- Price Target
- $31.00
- Year High
- $31.49
- Year Low
- $17.86
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.30
Company Overview
NASDAQ
Roderick de Greef
Medical - Instruments & Supplies
Healthcare
BLFS
155
US
USD
Liquidity Metrics
0.04
7.30
5.50
1.25
0.00
Sales & Valuation
$96.21M
15.25
4.06
-848.33
-0.04
Profitability
-$0.25
-$12.13M
-10.52%
-10.42%
-2.91%
-2.62%
P/E Metrics
-144.21
0.20
0.20
Analyst Price Target & Rating
$31.00
$31.00
$31.00
2/5
17 Analysts
0.48%
Financial Health Scores
29.11
5/9
$114.97M
$400.91M
$28.68M
-$12.26M
Key Metrics (TTM)
$1.42B
14.18
-189.71
7.30
-2.91%
-2.81%
-0.74%
-0.13%
342 days
Company Executives
| Name | Title |
|---|---|
| Roderick de Greef | Chief Executive Officer & Chairman |
| Todd Berard | Chief Commercial Officer |
| Sean Werner | Chief Technology Officer |
| Aby J. Mathew | Chairman of Scientific Advisory Board, Executive Vice President & Chief Scientific Officer |
| Troy Wichterman | Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About BioLife Solutions, Inc. (NASDAQ:BLFS) Stock
BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to pre ... cisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
2026-07-22 15:04:19
Repligen NASDAQ: RGEN said it has signed a definitive agreement to acquire BioLife Solutions in a transaction valued at approximately $1.5 billion, adding a cell therapy-focused platform that management said will expand Repligen's exposure to one of the faster-growing areas of bioprocessing.
2026-07-22 15:00:00
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (NASDAQ: BLFS) PR Newswire
2026-07-22 14:04:00
NEW YORK, July 22, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating BioLife Solutions, Inc. (NASDAQ: BLFS ) related to its sale to Repligen Corporation.
2026-07-22 12:00:00
Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price for Public Shareholders PR
2026-07-22 11:34:00
MILWAUKEE, July 22, 2026 /PRNewswire/ -- Ademi LLP is investigating BioLife (NASDAQ: BLFS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Repligen. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.
2026-07-22 10:00:00
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc. (NASDAQ: BLFS) to Repligen Corporation for $11.25 per share
Repligen Strengthens Cell Therapy Portfolio With BioLife Acquisition
2026-07-22 09:41:59
Life sciences company Repligen Corporation (NASDAQ:RGEN) on Wednesday agreed to acquire cell processing developer BioLife Solutions Inc. (NASDAQ:BLFS) for an enterprise value of approximately $1.5 billion.
2026-07-22 09:10:00
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc. (NASDAQ: BLFS) to Repligen Corporation for $11.25 per share in cash and 0.1442 shares of Repligen common stock. Halper Sadeh encourages BioLife shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns w.
Frequently Asked Questions
-
What is the current BioLife Solutions, Inc. (BLFS) stock price?
-
BioLife Solutions, Inc.(NASDAQ:BLFS) stock price is $31.15 in the last trading session. During the trading session, BLFS stock reached the peak price of $31.4935 while $17.86 was the lowest point it dropped to. The percentage change in BLFS stock occurred in the recent session was 6.71% while the dollar amount for the price change in BLFS stock was $1.96.
-
BLFS's industry and sector of operation?
-
The NASDAQ listed BLFS is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
-
Who are the executives of BLFS?
-
Roderick de Greef | Chief Executive Officer & Chairman
Todd Berard | Chief Commercial Officer
Sean Werner | Chief Technology Officer
Aby J. Mathew | Chairman of Scientific Advisory Board, Executive Vice President & Chief Scientific Officer
Troy Wichterman | Chief Financial Officer -
How many employees does BLFS have?
-
Number of BLFS employees currently stands at 155. BLFS operates from 3303 Monte Villa Parkway, Bothell, WA 98021, US.
-
Link for BLFS official website?
-
Official Website of BLFS is: https://www.biolifesolutions.com
-
How do I contact BLFS?
-
BLFS could be contacted at phone #425 402 1400 and can also be accessed through its website. BLFS operates from 3303 Monte Villa Parkway, Bothell, WA 98021, US.
-
How many shares of BLFS are traded daily?
-
The average number of BLFS shares traded daily for last 3 months was 775.48K.
-
What is the market cap of BLFS currently?
-
The market value of BLFS currently stands at $1.52B with its latest stock price at $31.15